| Literature DB >> 24820538 |
Thomas P White1, Eva Loth2, Katya Rubia3, Lydia Krabbendam4, Robert Whelan5, Tobias Banaschewski6, Gareth J Barker7, Arun L W Bokde8, Christian Büchel9, Patricia Conrod10, Mira Fauth-Bühler11, Herta Flor6, Vincent Frouin12, Jürgen Gallinat13, Hugh Garavan5, Penny Gowland14, Andreas Heinz13, Bernd Ittermann15, Claire Lawrence16, Karl Mann6, Marie-Laure Paillère17, Frauke Nees18, Tomas Paus19, Zdenka Pausova20, Marcella Rietschel6, Trevor Robbins21, Michael N Smolka22, Sukhwinder S Shergill1, Gunter Schumann2.
Abstract
Catecholamine-0-methyl-transferase (COMT) gene variation effects on prefrontal blood oxygenation-level-dependent (BOLD) activation are robust; however, despite observations that COMT is estrogenically catabolized, sex differences in its prefrontal repercussions remain unclear. Here, in a large sample of healthy adolescents stratified by sex and Val(158)Met genotype (n=1133), we examine BOLD responses during performance of the stop-signal task in right-hemispheric prefrontal regions fundamental to inhibitory control. A significant sex-by-genotype interaction was observed in pre-SMA during successful-inhibition trials and in both pre-SMA and inferior frontal cortex during failed-inhibition trials with Val homozygotes displaying elevated activation compared with other genotypes in males but not in females. BOLD activation in the same regions significantly mediated the relationship between COMT genotype and inhibitory proficiency as indexed by stop-signal reaction time in males alone. These sexually dimorphic effects of COMT on inhibitory brain activation have important implications for our understanding of the contrasting patterns of prefrontally governed psychopathology observed in males and females.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24820538 PMCID: PMC4207335 DOI: 10.1038/npp.2014.107
Source DB: PubMed Journal: Neuropsychopharmacology ISSN: 0893-133X Impact factor: 7.853